← FDA Drug Approvals (Drugs@FDA)

GLYCOPYRROLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2024-10-07

Drug application

FDA Application #

ANDA216297

Application type

Abbreviated New Drug Application (Generic)

Brand name

GLYCOPYRROLATE

Generic name

GLYCOPYRROLATE

Active ingredients

GLYCOPYRROLATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Saptalis Pharmaceuticals, LLC.

First approval

2024-10-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown